Jazz Pharmaceuticals and AbCellera ink antibody research deal
Go back to Jazz Pharmaceuticals and AbCellera ink antibody research deal| (NASDAQ: ABCL) | Delayed: 11.28 -0.2 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.48 | 52 Week High | $ | |||
| Open | $11.24 | 52 Week Low | $ | |||
| Day High | $11.52 | P/E | N/A | |||
| Day Low | $11.05 | EPS | $ | |||
| Volume | 4,248,057 | |||||
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 243.71 -6.97 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.68 | 52 Week High | $160.00 | |||
| Open | $250.13 | 52 Week Low | $95.80 | |||
| Day High | $252.50 | P/E | 45.30 | |||
| Day Low | $243.02 | EPS | $5.38 | |||
| Volume | 1,072,822 | |||||
